[Federal Register Volume 80, Number 31 (Tuesday, February 17, 2015)]
[Notices]
[Pages 8327-8328]
[FR Doc No: 2015-03116]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2015-N-0001]

Food and Drug Administration/Xavier University Global Medical
Device Conference; Public Conference

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of public conference.

-----------------------------------------------------------------------

    The Food and Drug Administration (FDA) Cincinnati District, in
cosponsorship with Xavier University, is announcing a public conference
entitled ``FDA/Xavier University Global Medical Device Conference
(MedCon).'' This 3-day public conference includes presentations from
key FDA officials and industry experts with small group breakout
sessions. The conference is intended for companies of all sizes and
employees at all levels.

DATES: Dates and Times: The public conference will be held on May 6,
2015, from 8:30 a.m. to 5 p.m.; May 7, 2015, from 8:30 a.m. to 5 p.m.;
and May 8, 2015, from 8:30 a.m. to 12:30 p.m.
    Location: The public conference will be held on the campus of
Xavier University, 3800 Victory Pkwy., Cincinnati, OH 45207, 513-745-
3016.
    Contact Persons: For information regarding this notice: Gina
Brackett, Food and Drug Administration, 6751 Steger Dr., Cincinnati, OH
45237,<PHONE_NUMBER>, FAX:<PHONE_NUMBER>, email:
<EMAIL_ADDRESS>    For information regarding the conference and registration: Mason
Rick, Xavier University, 3800 Victory Pkwy., Cincinnati, OH 45207-5471,
513-745-3016, email<EMAIL_ADDRESS>or visit http://www.XavierMedCon.com.
    Registration: There is a conference registration fee which covers
the cost of the presentations, training materials, receptions,
breakfasts, and lunches for the 3 days of the conference. Advanced
registration begins February 6, 2015. Standard registration begins
March 6, 2015. There will be onsite registration. The cost of
registration is as follows:

                     Table 1--Registration Fees \1\
------------------------------------------------------------------------
                                    Advanced rate  (2/   Standard rate
           Attendee type             6/15 to 3/5/15)     (after 3/5/15)
------------------------------------------------------------------------
Industry..........................             $1,495             $1,695
Small Business (<100 Employees)...              1,000              1,200
Startup Manufacturer..............                250                300
Academic..........................                250                300
FDA/Government Employee...........               Free               Free
------------------------------------------------------------------------
\1\ The following forms of payment will be accepted: American Express,
  Visa, MasterCard, and company checks.

    To register online for the public conference, please visit the
``Registration'' link on the conference Web site at http://www.XavierMedCon.com. FDA has verified the Web site address, but is not
responsible for subsequent changes to the Web site after this document
publishes in the Federal Register.
    To register by mail, please send your name, title, firm name,
address, telephone, email, and payment information for the fee to
Xavier University, Attention: Mason Rick, 3800 Victory Pkwy.,
Cincinnati, OH 45207-5471. An email will be sent confirming your
registration.
    Attendees are responsible for their own accommodations. The
conference headquarters hotel is the Downtown Hilton Cincinnati
Netherland Plaza, 35 West Fifth St., Cincinnati, OH 45202, 513-421-
9100. Special conference block rates are available through April 16,
2015. To make reservations online, please visit the ``Venue/Logistics''
link at http://www.XavierMedCon.com.
    If you need special accommodations due to a disability, please
contact Mason Rick (see Contact Persons) at least 7 days in advance of
the conference.

SUPPLEMENTARY INFORMATION: The public conference helps fulfill the
Department of Health and Human Services' and FDA's important mission to
protect the public health. The conference will provide those engaged in
FDA-regulated medical devices (for humans) with information on the
following topics:

 Center Director Corner: Strategic Priorities for 2015 and
Beyond
 Office of Compliance Strategic Priorities
 Advancements in Medical Device Software Technology
 Understanding and Preparing for the Revision of ISO13485
 Update from FDA's Office of Combination Products
 Unique Device Identification--Implementation
 FDA Inspections and Insights
 Understanding the Current Activities of the International
Medical Device Regulators Forum
 European Union Medical Device/In Vitro Diagnostics Regulation
Review
 Update from the Office of Device Evaluation
 Regulatory Submissions and Strategies
 Complaints, Corrective and Preventive Actions, and Recalls
 Regulatory Challenges in Asia
 Action Plan Writing
 Lunch Networking by Topic

    FDA has made education of the drug and device manufacturing
community a high priority to help ensure the quality of FDA-regulated
drugs and devices. The conference helps to achieve objectives set forth
in section 406 of the Food and Drug Administration Modernization Act of
1997 (21 U.S.C. 393), which includes working closely with stakeholders
and maximizing the availability and clarity of information to
stakeholders and the public. The conference also is consistent with the
Small Business Regulatory Enforcement Fairness Act of 1996 (Public Law
104-121) by providing outreach activities by Government agencies to
small businesses.

    Dated: February 10, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015-03116 Filed 2-13-15; 8:45 am]
BILLING CODE 4164-01-P


[Federal Register Volume 88, Number 147 (Wednesday, August 2, 2023)]
[Notices]
[Page 50888]
[FR Doc No: 2023-16356]

-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

Federal Emergency Management Agency

[Internal Agency Docket No. FEMA-4716-DR; Docket ID FEMA-2023-0001]

Commonwealth of the Northern Mariana Islands; Amendment No. 1 to
Notice of a Major Disaster Declaration

AGENCY: Federal Emergency Management Agency, DHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice amends the notice of a major disaster declaration
for the Commonwealth of the Northern Mariana Islands (FEMA-4716-DR),
dated June 2, 2023, and related determinations.

DATES: This amendment was issued June 22, 2023.

FOR FURTHER INFORMATION CONTACT: Dean Webster, Office of Response and
Recovery, Federal Emergency Management Agency, 500 C Street SW,
Washington, DC 20472,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION: Notice is hereby given that the incident
period for this disaster is closed effective May 29, 2023.

    The following Catalog of Federal Domestic Assistance Numbers
(CFDA) are to be used for reporting and drawing funds: 97.030,
Community Disaster Loans; 97.031, Cora Brown Fund; 97.032, Crisis
Counseling; 97.033, Disaster Legal Services; 97.034, Disaster
Unemployment Assistance (DUA); 97.046, Fire Management Assistance
Grant; 97.048, Disaster Housing Assistance to Individuals and
Households In Presidentially Declared Disaster Areas; 97.049,
Presidentially Declared Disaster Assistance--Disaster Housing
Operations for Individuals and Households; 97.050, Presidentially
Declared Disaster Assistance to Individuals and Households--Other
Needs; 97.036, Disaster Grants--Public Assistance (Presidentially
Declared Disasters); 97.039, Hazard Mitigation Grant.

Deanne Criswell,
Administrator, Federal Emergency Management Agency.
[FR Doc. 2023-16356 Filed 8-1-23; 8:45 am]
BILLING CODE 9111-23-P